Related Experiment Video
Updated: Aug 9, 2026
Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
Published on: October 1, 2012
Present potential of immunotoxins
Abstract:
Immuno-a-toxins (I-a-T) are hybrid molecules designed for a more selective therapy of cancer, which combine an antibody preferentially directed against tumour cells and the A-chain of the toxin ricin. Although a majority of them are highly and selectively cytotoxic to their target cells in vitro, only some of them gave rise to a therapeutic effect in animal models. In vitro kinetics studies suggested the importance of a rapid mode of action for in vivo efficacy, which is not the property of all I-a-T. Ways of accelerating and potentiating such conjugates are proposed, such as the use of lysosomotropic amines like ammonium chloride. Whereas the in vivo use of these activators is still under research, their in vitro use gives rise to a 99.99% cytoreduction of leukemic cells and thus is directly applicable to clinical situations such as bone marrow transplantations.
Insights
Immuno-a-toxins (I-a-T) show promise for targeted cancer therapy. Enhancing their action with compounds like ammonium chloride can significantly boost efficacy, particularly in vitro for applications like bone marrow transplantation.
Area of Science:
- Oncology
- Immunotherapy
- Molecular Biology
Background:
- Immuno-a-toxins (I-a-T) are engineered molecules combining antibodies and ricin toxin A-chains for targeted cancer cell destruction.
- While effective in vitro, many I-a-T lack significant therapeutic impact in animal models, suggesting limitations in their action kinetics.
Purpose of the Study:
- To investigate methods for accelerating and potentiating the efficacy of immuno-a-toxins.
- To explore the potential of lysosomotropic amines, such as ammonium chloride, as activators for I-a-T.
Main Methods:
- In vitro kinetic studies of immuno-a-toxin activity.
- Evaluation of lysosomotropic amines (e.g., ammonium chloride) to enhance I-a-T cytotoxicity.
Main Results:
- In vitro kinetic studies highlighted the need for rapid action for in vivo efficacy.
- Treatment with ammonium chloride resulted in a 99.99% cytoreduction of leukemic cells in vitro.
- In vivo application of these activators is still under investigation.
Conclusions:
- The efficacy of immuno-a-toxins is influenced by their mode of action kinetics.
- Lysosomotropic amines, like ammonium chloride, can significantly enhance I-a-T cytotoxicity in vitro.
- The in vitro findings suggest potential clinical applications, including bone marrow transplantation.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy